Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Minna

Showing results (221-230 of 286) with videos related to

Pageof 29
Sort By:
Cancer Research|May 15, 1993
Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancersO I Olopade, D L Buchhagen, K Malik, et al.
Oncogene|October 30, 1998
Mutation analysis of the PTEN/MMAC1 gene in lung cancerE Forgacs, E J Biesterveld, Y Sekido, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.
American Journal of Clinical Oncology|December 1, 1984
Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin CL A Doyle, D C Ihde, D N Carney, et al.
Cancer|May 1, 1985
The role of radiation therapy in the treatment of small cell lung cancerA S Lichter, P A Bunn, D C Ihde, et al.
Oncogene|January 1, 1992
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical featuresT Mitsudomi, S M Steinberg, M M Nau, et al.
The Journal of Clinical Investigation|July 1, 1988
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitroY Nakanishi, J L Mulshine, P G Kasprzyk, et al.
JAMA|November 14, 1980
Smoking abstinence and small cell lung cancer survival. An associationA Johnston-Early, M H Cohen, J D Minna, et al.
Cancer Treatment Reports|February 1, 1979
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinomaM H Cohen, D C Ihde, P A Bunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cellsJ M Horowitz, S H Park, E Bogenmann, et al.
Pageof 29

Showing results (221-230 of 286) with videos related to

Sort By:
Pageof 29
Cancer Research|May 15, 1993
Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancersO I Olopade, D L Buchhagen, K Malik, et al.
Oncogene|October 30, 1998
Mutation analysis of the PTEN/MMAC1 gene in lung cancerE Forgacs, E J Biesterveld, Y Sekido, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.
American Journal of Clinical Oncology|December 1, 1984
Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin CL A Doyle, D C Ihde, D N Carney, et al.
Cancer|May 1, 1985
The role of radiation therapy in the treatment of small cell lung cancerA S Lichter, P A Bunn, D C Ihde, et al.
Oncogene|January 1, 1992
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical featuresT Mitsudomi, S M Steinberg, M M Nau, et al.
The Journal of Clinical Investigation|July 1, 1988
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitroY Nakanishi, J L Mulshine, P G Kasprzyk, et al.
JAMA|November 14, 1980
Smoking abstinence and small cell lung cancer survival. An associationA Johnston-Early, M H Cohen, J D Minna, et al.
Cancer Treatment Reports|February 1, 1979
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinomaM H Cohen, D C Ihde, P A Bunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cellsJ M Horowitz, S H Park, E Bogenmann, et al.
Pageof 29